We focused on the detection of specific cancer markers from malignant melanoma, using the BRAF gene (gene B of Rapid Acceleration of Fibrosarcoma) [26] using RNA targets isolated by a simple nucleic acid extraction step from natural samples, such as tissue culture melanoma cells [27]. The gene discussed is BRAF; the disease is melanoma.